Disease | c1 inhibitor deficiency |
Phenotype | C0019243|hereditary angioedema |
Sentences | 28 |
PubMedID- 20664282 | Background: hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh) is characterized by recurrent edema attacks in various organs. |
PubMedID- 26512744 | Current treatment options for hereditary angioedema due to c1 inhibitor deficiency. |
PubMedID- 26154504 | hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) is characterized by relapsing, non-pruritic swelling in skin and submucosal tissue. |
PubMedID- 22677048 | [update in hereditary angioedema due to c1 inhibitor deficiency]. |
PubMedID- 25758562 | A nationwide survey of hereditary angioedema due to c1 inhibitor deficiency in italy. |
PubMedID- 23653967 | Management of dental-oral procedures in patients with hereditary angioedema due to c1 inhibitor deficiency. |
PubMedID- 22817696 | hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh) is a genetic disease that reduces the synthesis or function of c1 inhibitor (c1-inh) [1]. |
PubMedID- 24411585 | hereditary angioedema (hae) due to c1 inhibitor deficiency is a rare disease characterized by attacks of edema, known to impact quality of life (qol). |
PubMedID- 25475444 | Background: danazol, a drug extensively used in the management of hereditary angioedema due to c1 inhibitor deficiency (c1-inh-hae), has various side effects. |
PubMedID- 21601496 | Objective: tooth extractions may trigger clinical symptoms of hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh). |
PubMedID- 23937903 | hereditary angioedema with c1 inhibitor deficiency: delay in diagnosis in europe. |
PubMedID- 25054967 | Context and objective: hereditary angioedema (hae) with c1 inhibitor deficiency manifests as recurrent episodes of edema involving the skin, upper respiratory tract and gastrointestinal tract. |
PubMedID- 21760740 | Ecallantide is a novel treatment for attacks of hereditary angioedema due to c1 inhibitor deficiency. |
PubMedID- 26535898 | hereditary angioedema due to c1 inhibitor deficiency (c1-inh-hae) is a rare autosomal dominant disease characterized by recurrent life-threatening oedemas and/or abdominal pain and caused by mutations affecting the c1 inhibitor gene, serping1. |
PubMedID- 23634741 | Therapeutic management of hereditary angioedema due to c1 inhibitor deficiency. |
PubMedID- 24054366 | hereditary angioedema with c1 inhibitor deficiency: clinical presentation and quality of life of 193 french patients. |
PubMedID- 26304015 | Efficacy of on-demand treatment in reducing morbidity in patients with hereditary angioedema due to c1 inhibitor deficiency. |
PubMedID- 25669442 | Recombinant human c1 esterase inhibitor for the treatment of hereditary angioedema due to c1 inhibitor deficiency (c1-inh-hae). |
PubMedID- 22288585 | The autoreactivity of b cells in hereditary angioedema due to c1 inhibitor deficiency. |
PubMedID- 22909164 | Background: hereditary angioedema (hae) owing to c1 inhibitor deficiency is an autosomal dominant disorder, characterized by recurrent, potentially life-threatening, localized attacks of tissue swelling. |
PubMedID- 26250409 | Recombinant replacement therapy for hereditary angioedema due to c1 inhibitor deficiency. |
PubMedID- 25924832 | Background: attacks of hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) are commonly treated in the emergency department. |
PubMedID- 20818886 | Background: hereditary angioedema due to c1 inhibitor deficiency is characterized by recurrent acute attacks of swelling that can be painful and sometimes life-threatening. |
PubMedID- 22841766 | Background: hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh) is characterized by relapsing skin swellings, abdominal pain attacks, and, less frequently, potentially life-threatening laryngeal attacks. |
PubMedID- 20804470 | Mutational spectrum and phenotypes in danish families with hereditary angioedema because of c1 inhibitor deficiency. |
PubMedID- 26016741 | Background: hereditary angioedema (hae) due to c1 inhibitor deficiency manifests as recurrent swelling attacks that can be disabling and sometimes fatal. |
PubMedID- 26429506 | hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) is the best characterized form of hereditary angioedema. |
PubMedID- 24996814 | Background: hereditary angioedema (hae) due to c1 inhibitor deficiency is a rare but serious and potentially life-threatening disease marked by spontaneous, recurrent attacks of swelling. |
Page: 1